Ex vivo gene editing and cell therapy for hereditary tyrosinemia type 1.
Ates I, Stuart C, Rathbone T, Barzi M, He G, Major AM, Shankar V, Lyman RA, Angner SS, Mackay TFC, Srinivasan S, Farris AB, Bissig KD, Cottle RN.
Ates I, et al. Among authors: he g.
Hepatol Commun. 2024 Apr 26;8(5):e0424. doi: 10.1097/HC9.0000000000000424. eCollection 2024 May 1.
Hepatol Commun. 2024.
PMID: 38668730